News

Where Are They Now? Jamie Flerlage, MD, MS

Where Are They Now? Jamie Flerlage, MD, MS When did you become interested in the study of medicine? In lymphoma specifically? After realizing in high school that only 1% of astronauts went to space, I shifted my love for science…

Donor Spotlight: Steve Prince

Steven “Steve” J. Prince, former Chair of the Lymphoma Research Foundation’s Board of Directors and current Director Emeritus, grew up in a New York family that prioritized giving back – a tradition he has continued.

Researcher Spotlight: Jennifer Brown, MD, PhD

For over 20 years, Dr. Brown has led teams at Dana- Farber Cancer Institute to new understandings of chronic lymphocytic leukemia (CLL) and run clinical trials that have improved outcomes for countless patients.

Lymphoma Research Foundation to Honor Longtime Foundation Supporter and Past Board Chair Steven J. Prince at Annual Gala on September 25

Lymphoma Research Foundation to Honor Longtime Foundation Supporter and Past Board Chair Steven J. Prince at Annual Gala on September 25 BeiGene will be presented with the Lymphoma Research Foundation’s Corporate Leadership Award for excellence in development of next-generation cancer…

Lymphoma Research Foundation Elects Kristi Hendriks to Esteemed Board of Directors

The Lymphoma Research Foundation – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – today announced the election of Kristi Hendriks of Boston, MA to its Board of Directors. 

Lymphoma Research Foundation Elects New Scientific Advisory Board Members

Lymphoma Research Foundation Elects New Scientific Advisory Board Members Foundation welcomes four world-leading lymphoma experts to contribute to the global impact of the Foundation and guide the Foundation’s research portfolio The Lymphoma Research Foundation is proud to welcome four new…

The U.S. Food and Drug Administration (FDA) Grants Accelerated Approval to Epcoritamab-Bysp (Epkinly) for Relapsed or Refractory Follicular Lymphoma

On June 26, 2024, the U.S. Food and Drug Administration (FDA) announced it has granted accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.) for adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines…

Donor Spotlight: Leigh Olson

Major donor, Leigh Olson’s experience with the Lymphoma Research Foundation started in a doctor’s waiting room.

Conquering the Unknowns in Lymphoma

Thomas Habermann, MD, a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, and former Chair of the Lymphoma Research Foundation’s Scientific Advisory Board (SAB) brings passion and drive to every study he works on and every patient he works with.

Where Are They Now? Lymphoma Rounds 15 Years In Review

Since 2008, Lymphoma Rounds programs provide a forum for healthcare professionals to meet regularly and address issues specific to the diagnosis and treatment of their lymphoma patients.

Subscribe to Our Emails. Get lymphoma and CLL resources and updates.